Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313359563> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4313359563 endingPage "177.18" @default.
- W4313359563 startingPage "177.18" @default.
- W4313359563 abstract "Abstract We used three different murine mammary carcinoma, each syngeneic in Balb/c mice, to study the early anti-tumor immune response. Initial analysis showed that the number of cells at the tumor sites almost doubled between 12–72 hours going from about 3e5 cells at 12 hours to about 6e5 cells at 72 hours. Surface staining revealed that the immune response during this time period was predominated by Gr1+ and F4/80+ cells. Strikingly, similar cell numbers and cell types were recruited to saline injected sites suggesting that these cells may be recruited non-specifically. However, closer examination revealed significant differences not only between the saline and tumor injected sites, but also among different tumor sites. For instance, at 12 hours post injection there were significantly more Gr1+ cells at the EMT6 tumor site than at the 4T1 tumor site, and at 48 hours there were significantly more Gr1+ cells at the 168 tumor site than at the saline and 4T1 tumor sites. At 24 hours post injection there were significantly more F4/80+ cells at the EMT6 tumor site than at the 4T1, 168 and saline injected sites, and at 72 hours post injection there were significantly more F4/80+ cells at the EMT6 tumor site compared to the 4T1 and 168 tumor sites. Next, we collected the Gr1+ and F4/80+ cells from the sites 24 hours after tumor delivery and using qRT-PCR we found several additional differences. For instance, the Gr1+ cells from the EMT6 tumor site expressed more arginase and less CCL2 than the Gr1+ cells from the 4T1 and 168 tumor sites, and the F4/80+ cells from the EMT6 site expressed more MMP-9 and TNF-a than F4/80+ cells from the 4T1 and 168 tumor sites. Collectively, these data indicated that a unique anti-tumor immune response was evident within hours of tumor delivery." @default.
- W4313359563 created "2023-01-06" @default.
- W4313359563 creator A5036985869 @default.
- W4313359563 creator A5054493553 @default.
- W4313359563 creator A5056841310 @default.
- W4313359563 creator A5070183375 @default.
- W4313359563 creator A5086026353 @default.
- W4313359563 creator A5090915486 @default.
- W4313359563 date "2018-05-01" @default.
- W4313359563 modified "2023-10-18" @default.
- W4313359563 title "Distinct innate immune responses to different murine mammary carcinoma are evident within the first 72 hours of tumor injection" @default.
- W4313359563 doi "https://doi.org/10.4049/jimmunol.200.supp.177.18" @default.
- W4313359563 hasPublicationYear "2018" @default.
- W4313359563 type Work @default.
- W4313359563 citedByCount "0" @default.
- W4313359563 crossrefType "journal-article" @default.
- W4313359563 hasAuthorship W4313359563A5036985869 @default.
- W4313359563 hasAuthorship W4313359563A5054493553 @default.
- W4313359563 hasAuthorship W4313359563A5056841310 @default.
- W4313359563 hasAuthorship W4313359563A5070183375 @default.
- W4313359563 hasAuthorship W4313359563A5086026353 @default.
- W4313359563 hasAuthorship W4313359563A5090915486 @default.
- W4313359563 hasConcept C121608353 @default.
- W4313359563 hasConcept C126322002 @default.
- W4313359563 hasConcept C134018914 @default.
- W4313359563 hasConcept C142724271 @default.
- W4313359563 hasConcept C203014093 @default.
- W4313359563 hasConcept C2776187077 @default.
- W4313359563 hasConcept C2777397205 @default.
- W4313359563 hasConcept C2777546739 @default.
- W4313359563 hasConcept C2994001847 @default.
- W4313359563 hasConcept C3020616263 @default.
- W4313359563 hasConcept C502942594 @default.
- W4313359563 hasConcept C530470458 @default.
- W4313359563 hasConcept C71924100 @default.
- W4313359563 hasConcept C86803240 @default.
- W4313359563 hasConcept C8891405 @default.
- W4313359563 hasConceptScore W4313359563C121608353 @default.
- W4313359563 hasConceptScore W4313359563C126322002 @default.
- W4313359563 hasConceptScore W4313359563C134018914 @default.
- W4313359563 hasConceptScore W4313359563C142724271 @default.
- W4313359563 hasConceptScore W4313359563C203014093 @default.
- W4313359563 hasConceptScore W4313359563C2776187077 @default.
- W4313359563 hasConceptScore W4313359563C2777397205 @default.
- W4313359563 hasConceptScore W4313359563C2777546739 @default.
- W4313359563 hasConceptScore W4313359563C2994001847 @default.
- W4313359563 hasConceptScore W4313359563C3020616263 @default.
- W4313359563 hasConceptScore W4313359563C502942594 @default.
- W4313359563 hasConceptScore W4313359563C530470458 @default.
- W4313359563 hasConceptScore W4313359563C71924100 @default.
- W4313359563 hasConceptScore W4313359563C86803240 @default.
- W4313359563 hasConceptScore W4313359563C8891405 @default.
- W4313359563 hasIssue "1_Supplement" @default.
- W4313359563 hasLocation W43133595631 @default.
- W4313359563 hasOpenAccess W4313359563 @default.
- W4313359563 hasPrimaryLocation W43133595631 @default.
- W4313359563 hasRelatedWork W1576485543 @default.
- W4313359563 hasRelatedWork W1931562533 @default.
- W4313359563 hasRelatedWork W1989497964 @default.
- W4313359563 hasRelatedWork W2001014107 @default.
- W4313359563 hasRelatedWork W2021113625 @default.
- W4313359563 hasRelatedWork W2047092707 @default.
- W4313359563 hasRelatedWork W2082667204 @default.
- W4313359563 hasRelatedWork W2140498192 @default.
- W4313359563 hasRelatedWork W2326435862 @default.
- W4313359563 hasRelatedWork W2414632376 @default.
- W4313359563 hasVolume "200" @default.
- W4313359563 isParatext "false" @default.
- W4313359563 isRetracted "false" @default.
- W4313359563 workType "article" @default.